Home Tags R&D
The FDA just turned away Alkermes' approval submission for its new drug to treat major depressive disorder.
TwoXar, a startup that uses software to discover new, experimental drugs, just raised $10 million from investors including SoftBank Ventures.
There's a reason why all sorts of breakthrough technologies developed by researchers go ignored.
Apple spent $2.8 billion on R&D last quarter. That's up from $2.4 billion a year ago. Here's what Apple could be spending its R&D money on.
Tesla Motors is playing the long game.
Bob Abraham, Pfizer's head of oncology research and development, tells Business Insider what it takes to find out which medicines are going to go the distance.